Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 151 |
Danske Bank
Copenhagen K,
Denmark
| $1.68B | +$60.4M | 30 | 3.33% | Increased |
|
| 152 |
New York State Teachers Retirement System (NYSTRS)
Albany,
New York
| $1.66B | -$87.8M | 19 | 3.07% | Reduced |
|
| 153 |
Deep Track Capital
Greenwich,
Connecticut
| $1.64B | -$73.3M | 18 | 23.91% | Reduced |
|
| 154 |
KBC Group
Brussels,
Belgium
| $1.63B | +$43.7M | 43 | 3.53% | Increased |
|
| 155 |
EC
EcoR1 Capital
San Francisco,
California
| $1.63B | -$548M | 14 | 79.07% | Reduced |
|
| 156 |
Cerity Partners
New York
| $1.62B | +$19.9M | 66 | 1.96% | Increased |
|
| 157 |
Nomura Asset Management International
Philadelphia,
Pennsylvania
| $1.62B | +$33.9M | 45 | 2.43% | Increased |
|
| 158 |
Holocene Advisors
New York
| $1.61B | -$667M | 16 | 3.62% | Reduced |
|
| 159 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $1.6B | +$50.2M | 53 | 2.45% | Increased |
|
| 160 |
OrbiMed
New York
| $1.6B | +$14.6M | 34 | 29.66% | Increased |
|
| 161 |
Fuller & Thaler Asset Management
San Mateo,
California
| $1.59B | +$122M | 8 | 4.32% | Increased |
|
| 162 |
Credit Agricole
Montrouge Cedex,
France
| $1.59B | +$277M | 24 | 3.22% | Increased |
|
| 163 |
Jane Street
New York
| $1.57B | +$213M | 131 | 0.13% | Increased |
|
| 164 |
Harris Associates
Chicago,
Illinois
| $1.55B | -$34.4M | 2 | 2.06% | Reduced |
|
| 165 |
M&G plc
London,
United Kingdom
| $1.52B | +$35.8M | 11 | 7.57% | Increased |
|
| 166 |
SL
Siren LLC
Greenwich,
Connecticut
| $1.51B | +$150M | 23 | 30.6% | Increased |
|
| 167 |
Eurizon Capital SGR SpA
Milan,
| $1.51B | -$41M | 23 | 4.04% | Reduced |
|
| 168 |
Lord, Abbett & Co
Jersey City,
New Jersey
| $1.5B | -$338M | 16 | 4.31% | Reduced |
|
| 169 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1.49B | +$248M | 143 | 0.12% | Increased |
|
| 170 |
GS
Gilead Sciences
Foster City,
California
| $1.48B | -$772M | 3 | 89.47% | Reduced |
|
| 171 |
Bellevue Group
Kuesnacht,
Switzerland
| $1.47B | +$73.6M | 30 | 31% | Increased |
|
| 172 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
| $1.46B | +$16.8M | 33 | 3.19% | Increased |
|
| 173 |
Sanders Capital
West Palm Beach,
Florida
| $1.45B | -$21.8M | 2 | 1.45% | Reduced |
|
| 174 |
Chevy Chase Trust
Bethesda,
Maryland
| $1.45B | -$40.1M | 13 | 3.73% | Reduced |
|
| 175 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
| $1.43B | +$171M | 30 | 2.41% | Increased |
|